MUC13 is upregulated during IBD (Sheng et al., 2011; Breugelmans et al., 2020) and colorectal cancer (Williams et al., 2001; Gupta et al., 2012), correlating with increased pro-inflammatory responses (Sheng et al., 2013), cell growth and migration (Gupta et al., 2014; Khan et al., 2017). Here, MUC13 is linked to colorectal cancer.